News

Five new super hospitals underway in Denmark

21 April 2017 | 12:48 pm
university-hospital-aarhus-cf-moller
The construction of five new national super hospitals with health IT infrastructure is now well underway in Denmark, reports Invest in Denmark. Danish hospitals have been co-developing innovative healthcare solutions with the industry for many years. This approach is now extended to a core methodology in a so-called intelligent hospital construction. 5 new national super […]
News

Vironova awarded US patent for further automation of TEM

21 April 2017 | 12:39 pm
vironova-minitem
Vironova has been granted a US patent with the title “A method for automatic correction of astigmatism”. Their method removes a manual step that requires considerable operator skill. It can be applied to any electron microscope, allowing for automated correction of the electron beam and ultimately enabling fully automated image acquisition. An important feature of […]
News

Scandinavian Biopharma in agreement with Flynn Pharma

21 April 2017 | 12:22 pm
björn-sjöstrand-agreement
Scandinavian Biopharma has entered into an agreement with Flynn Pharma for the viper antivenom ViperaTAb. Under the agreement, Scandinavian Biopharma will have exclusive rights to service and make ViperaTAb available for emergency use in the Nordics, Baltic States and Germany. “We are very pleased to strengthen our portfolio with an important antivenom for Northern Europe” […]
News

SciLifeLab offers funding for national genomics studies

20 April 2017 | 11:10 am
scilifelab
SciLifeLab welcomes applications for Swedish research projects based on next generation DNA sequencing. In total, this third call will provide 30 million SEK in support for sequence analysis of unique and wellcharacterized sample collections to study either the genetic basis of disease or environmental effects on biodiversity. The Swedish Genomes Program and the Swedish Biodiversity […]
News

Cobra Biologics expands gene therapy manufacturing operations

18 April 2017 | 11:44 am
peter-coleman
Cobra Biologics has announced the company’s expansion of operations at its sites in UK and Sweden. Over the next two years Cobra will invest up to £15m (165m SEK) on a phased expansion plan, supporting the company’s R&D expertise in developing rapid and cost effective viral vector and DNA plasmid production platforms. The initial phase, will […]
News

Mobidiag’s brand hits shelves in Italy

11 April 2017 | 8:46 am
CEO_Tuomas_Tenkanen_GeneSpress
Under the three-year agreement, AB ANALITICA is the exclusive distributor of Mobidiag’s brand Amplidiag in vitro diagnostics for gastrointestinal infections in Italy. AB Analitica is specialized in the development and the sale of diagnostic systems for professional use. “For the past months, we have been significantly extending our in vitro diagnostics suite of products,” says […]
News

Vaccibody moves forward with clinical study

10 April 2017 | 9:28 am
Martin-Bonde-vaccibody
Norwegian company Vaccibody is moving forward with the first vaccination of a patient with the human papillomavirus, HPV-virus, in a phase IIa study using the company´s immunotherapy platform. The primary objectives of the phase IIa study are to assess T cell mediated immune responses in the peripheral blood and to evaluate early signs of efficacy. […]
News

SCA becomes two listed companies

10 April 2017 | 9:21 am
magnus-groth-sca
At the Annual General Meeting of SCA last week, the company’s shareholders voted in favor of the Board of Director’s proposal to split the Group into two listed companies. Essity One of these will continue to operate as SCA, a forest products company that will include the forest products operations and all forest land currently […]
News

First patient included in Umecrine’s study

10 April 2017 | 9:12 am
umecrine
Karolinska Development’s portfolio company Umecrine Cognition announces the inclusion of the first patient in a clinical Phase Ib/IIa study of GR3027, which is in development as a potential new treatment for Hepatic Encephalopathy. The objectives of the study (protocol UCAB-CT-02) are to evaluate the safety and pharmacokinetics of steady-state dosing in healthy adults and patients […]
News

New international owner of Medfiles Ltd from Japan

10 April 2017 | 8:46 am
medfiles
On the 21st of March 2017, WDB Holdings Co., Ltd, a listed Japanese Contract Research Organisation, bought Medfiles Ltd (100 % of the shares). Medfiles Group has been operating in Finland for over 30 years and 20 years in the Baltic countries. In the CRO business, Medfiles sells services in product development, laboratory analytics and QP certification […]